Priming of synaptic vesicles (SVs) is essential for synaptic transmission. UNC-13 proteins are required for priming. Current models propose that UNC-13 stabilizes the open conformation of Syntaxin, in which the SNARE helix is available for interactions with Synaptobrevin and SNAP-25. Here we show that Tomosyn inhibits SV priming. Tomosyn contains a SNARE motif, which forms an inhibitory SNARE complex with Syntaxin and SNAP-25. Mutants lacking Tomosyn have increased synaptic transmission, an increased pool of primed vesicles, and increased abundance of UNC-13 at synapses. Behavioral, imaging, and electrophysiological studies suggest that SV priming was reconstituted in unc-13 mutants by expressing a constitutively open mutant Syntaxin, or by mutations eliminating Tomosyn. Thus, priming is modulated by the balance between Tomosyn and UNC-13, perhaps by regulating the availability of open-Syntaxin. Even when priming was restored, synaptic transmission remained defective in unc-13 mutants, suggesting that UNC-13 is also required for other aspects of secretion.
Introduction
Secretion of neurotransmitters at synapses is mediated by exocytosis of synaptic vesicles (SVs). SVs are initially recruited to and docked on the plasma membrane. Only a subset of these docked vesicles is competent to undergo calcium-evoked fusion (Rosenmund and Stevens, 1996) . This has led to the concept that docked vesicles must first be ''primed'' to become fusion competent. Fusion of primed vesicles with the plasma membrane is triggered by calcium influx following depolarization of the presynaptic terminal. SV fusion is promoted by formation of SNARE complexes comprised of vesicle (v-SNARE, e.g., Synaptobrevin [SNB-1]/VAMP) and plasma membrane (t-SNARE, e.g., proteins. Assembly of the SNARE complex forces the vesicle and plasma membranes into close proximity, which is proposed to trigger membrane fusion (Lin and Scheller, 2000; Weber et al., 1998) .
Several SNARE-interacting proteins are thought to regulate aspects of the vesicle cycle (Gerst, 2003) . For example, mutants lacking UNC-13 have a profound reduction in neurotransmitter secretion and nearly eliminate the pool of primed vesicles (Aravamudan et al., 1999; Augustin et al., 1999; Richmond et al., 1999) . These results have led to the conclusion that UNC-13 proteins are essential biochemical components of the vesicle-priming mechanism. A current model for priming involves regulation of the conformational state of Syntaxin. Syntaxin adopts either of two conformations-open and closed-such that only the open conformation is able to form SNARE complexes and thus participate in SV fusion. UNC-13 proteins interact with the amino-terminal regulatory domain of Syntaxin (Betz et al., 1997; Madison et al., 2005) , which would be predicted to stabilize the open conformation. In C. elegans, expression of a constitutively open mutant form of Syntaxin (Dulubova et al., 1999) partially corrected the secretion defects observed in unc-13 mutants , suggesting that UNC-13 promotes the formation or availability of open-Syntaxin.
Two results cast doubt on this ''opener'' hypothesis. First, although expression of open-Syntaxin in unc-13 mutants was sufficient to restore stimulus-evoked secretion, the rate of endogenous vesicle fusions (i.e., those evoked by endogenous nervous system activity) and locomotion behavior were not restored ). These results suggest that open-Syntaxin was unable to restore sufficient levels of SV fusion to support normal levels of synaptic transmission and behavior. Second, mutations disrupting the UNC-13 interaction with Syntaxin reduced (but did not eliminate) exocytosis of secretory granules and SVs; however, disrupting this interaction had no apparent effect on SV priming (Madison et al., 2005; Stevens et al., 2005) . Thus, the UNC-13-Syntaxin interaction may not be required for SV priming, contrary to the opener hypothesis. For these reasons, the function of UNC-13 and open-Syntaxin in SV priming remains uncertain.
Tomosyn contains a carboxy-terminal SNARE motif, homologous to Synaptobrevin, which forms an inhibitory complex with the t-SNAREs Syntaxin and SNAP-25 (Fujita et al., 1998; Hatsuzawa et al., 2003; Pobbati et al., 2004; Widberg et al., 2003) . Overexpression of Tomosyn in neurosecretory cells inhibits dense core vesicle (DCV) exocytosis (Constable et al., 2005; Hatsuzawa et al., 2003; Yizhar et al., 2004) . These results were consistent with the idea that Tomosyn inhibits priming of DCVs; however, recently published results suggest that depletion of Tomosyn by RNAi decreased synaptic transmission in Superior Cervical Ganglion neurons (Baba et al., 2005) . Similarly, inactivation of the yeast Tomosyn proteins (Sro7p and Sro77p) also leads to decreased secretion (Lehman et al., 1999) . Thus, the functional impact of Tomosyn on exocytosis remains uncertain, particularly for synaptic vesicles.
Recently, we showed that C. elegans mutants lacking TOMO-1 Tomosyn have behavioral defects and pharmacological responses that are consistent with enhanced acetylcholine (ACh) secretion at neuromuscular junctions (NMJs) . Here we characterize the roles of Tomosyn and UNC-13 as antagonistic regulators of synaptic transmission, likely by balancing the amount of Syntaxin available for priming.
Results

Loss of Tomosyn Increases ACh Secretion
The inhibitory effects of Tomosyn on secretion have been analyzed by overexpression in chromaffin cells (Hatsuzawa et al., 2003; Yizhar et al., 2004) . To determine the effect of Tomosyn on SV exocytosis, we recorded excitatory postsynaptic currents (EPSCs) from tomo-1 mutant body muscles. We found that the EPSC amplitudes and the total synaptic charge transfer evoked by a depolarizing stimulus were significantly increased in tomo-1 mutants ( Figures 1A-1D ). In addition, the decay kinetics of EPSCs measured in tomo-1 mutants were consistently slower than those in wild-type EPSCs ( Figure 1C ). The total charge and kinetics of endogenous EPSCs in tomo-1 mutants were not significantly different from wild-type (see Figure S1 in the Supplemental Data). These results suggest that tomo-1 mutants have increased ACh secretion, consistent with the increased sensitivity of these mutants to the paralytic effects of aldicarb . Thus, Tomosyn normally inhibits synaptic transmission.
GFP-Tagged Tomosyn Is Enriched at Presynaptic Elements
If Tomosyn plays a direct role in regulating synaptic transmission, we would expect that Tomosyn would be localized at nerve terminals. To test this idea, we visualized the distribution of GFP-tagged Tomosyn (TOMO-1::GFP) in cholinergic motorneurons. Expression of TOMO-1::GFP was sufficient to partially rescue the aldicarb hypersensitivity phenotype of tomo-1 mutants, suggesting that this chimeric protein retains activity ( Figure S2 ). In wild-type animals, TOMO-1::GFP fluorescence was diffusely distributed in axons, with some accumulation in puncta ( Figure 1E ). In mutants defective for SV exocytosis, the diffuse TOMO-1::GFP axonal fluorescence significantly decreased, while puncta Stimulus-evoked responses were recorded from body wall muscles of adult animals. (A) Averaged stimulus-evoked responses for wild-type (n = 5) and tomo-1(nu468) (n = 5) are compared. The stimulus artifact was blanked for clarity. (B) The peak amplitude was measured and compared for each response in (A). (C) Differences in the decay kinetics of wild-type and tomo-1(nu468) EPSCs are illustrated by comparing the averaged normalized responses. When decay kinetics were fit to a double exponential, the weighted average time constants for the EPSC decay phases of tomo-1 (t = 12 6 1 ms [n = 5]) and wild-type (t = 4 6 1 ms [n = 5] were significantly different (p < 0.01, Mann-Whitney). (D) The total synaptic charge for a 250 ms period following the stimulus was measured and compared for wild-type and tomo-1(nu468). (E-F) Colocalization of TOMO-1::GFP (Green) and RFP::SNB-1 (Red) in dorsal cord processes of DA motor neurons (expressed with the unc-129 promoter) in wild-type (E) and unc-13(s69) (F) animals. Images were superimposed to illustrate colocalization. (G-H) Distribution of TOMO-1::GFP in the dorsal (G) or ventral (H) nerve cords of wild-type (n = 10) and unc-104 KIF1A (n = 10) mutants are compared. TOMO-1::GFP axon fluorescence (DNC) decreased while cell body fluorescence (VNC) increased in unc-104(e1265) mutants. (I-J) Quantitation of TOMO-1::GFP fluorescence in wild-type (n = 35) and unc-13 (n = 34) mutants. (I) Diffuse axon fluorescence decreased in unc-13 mutants (p = 1 3 10 210 ). (J) Peak fluorescence increased slightly in unc-13 mutants (p = 0.035). (K) Quantitation of TOMO-1::GFP dorsal cord fluorescence, which decreased by 57% in unc-104(e1265) mutants (p = 6 3 10 25 ). Scale bars, 10 mm. Values that differ significantly from wild-type using the Mann-Whitney test (*p < 0.05, **p < 0.01, [B] and [D] ) or the Student's t test (**p < 0.0001, [G] and [M] ) are indicated. Error bars = SEM. fluorescence slightly increased ( Figures 1E, 1F , 1I, and 1J). For example, in unc-13 mutants, there was a net concentration of TOMO-1::GFP at puncta (change in puncta fluorescence/change in axon fluorescence was 330% versus wild-type, p < 6.0 3 10 217 ). Similar changes in TOMO-1::GFP distribution were observed in three other exocytosis mutants: unc-64 Syntaxin, ric-4 SNAP-25, and unc-18 Munc18 ( Figure S2 ). In both wild-type and in unc-13 mutants, TOMO-1::GFP was strikingly colocalized with RFP-tagged Synaptobrevin (RFP::SNB-1) ( Figures 1E and 1F) . A deletion mutant removing the SNARE helix (TOMO-1DHelix::GFP) also had a punctate distribution in unc-13 mutants ( Figure S2 ), suggesting the amino terminal domain of TOMO-1, containing the WD40 repeats, was sufficient to promote targeting to presynaptic elements.
Prior ultrastructural studies have shown that exocytosis mutants (e.g., unc-13 and unc-18) have a significant increase in the number of SVs found at nerve terminals (Richmond et al., 1999; Weimer et al., 2003) . The preceding results indicate that there is a corresponding increase in TOMO-1::GFP at these mutant synapses, suggesting that synaptic TOMO-1::GFP and the number of SVs were correlated. To further examine the relationship between SVs and Tomosyn, we analyzed the distribution of TOMO-1::GFP in unc-104 KIF1A mutants. The UNC-104 KIF1A motor protein is required for anterograde transport of synaptic vesicle precursors in both C. elegans and mice (Hall and Hedgecock, 1991; Okada et al., 1995) . TOMO-1::GFP axonal fluorescence decreased 57% in unc-104 KIF1A mutants, and this was accompanied by increased TOMO-1::GFP fluorescence in the cell bodies of ventral cord motor neurons ( Figures  1G, 1H , and 1K). These results suggest that the subcellular distribution of Tomosyn is coupled in some manner to anterograde transport of SV precursors. The presence of Tomosyn at presynaptic elements (particularly in exocytosis mutants) suggests that Tomosyn acts at presynaptic elements to inhibit some aspect of the SV cycle. We next tested several potential models for how Tomosyn inhibits synaptic transmission.
Loss of Tomosyn Does Not Alter Synapse Density
The behavioral and synaptic defects observed in tomo-1 mutants might be caused by an increase in the number of cholinergic NMJs, which would lead to increased ACh secretion. We tested this possibility in several ways. If the number of NMJs were increased, we would expect to find an increase in the frequency of endogenous EPSCs, i.e., synaptic vesicle fusions evoked by endogenous activity of motor neurons. However, the frequency of endogenous EPSCs in tomo-1 mutants was not significantly different from that found in wild-type controls (Figures 2A and 2B ). We also examined localization of two active zone proteins, SYD-2 a-Liprin and UNC-10 RIM1 (Koushika et al., 2001; Zhen and Jin, 1999) . We found that GFP-tagged SYD-2 a-Liprin and endogenously expressed UNC-10 RIM1 (visualized with anti-UNC-10 RIM1 antibodies) had similar distributions in wild-type and tomo-1 mutants ( Figures 2C and 2D ). Finally, we visualized presynaptic elements with GFP-tagged Synaptobrevin (GFP::SNB-1) and found that the density of GFP::SNB-1 puncta in wild-type controls and in tomo-1 mutants were indistinguishable (3.3 puncta/10 mm for both genotypes, p = 0.71, Student's t test). Consequently, loss of Tomosyn did not alter the distribution of active zone proteins, active zone morphology, or the apparent number of active zones. These results suggest that the increased synaptic transmission observed in tomo-1 mutants is unlikely to be explained by increased synapse density.
Loss of Tomosyn Does Not Alter the Distribution of t-SNAREs
Vertebrate Tomosyn binds the t-SNARE Syntaxin (Fujita et al., 1998; Hatsuzawa et al., 2003; Pobbati et al., 2004) . We analyzed the association of GFP-tagged Tomosyn with Syntaxin isolated from extracts of transgenic worms. UNC-64 Syntaxin was efficiently recovered from immunoprecipitates formed with anti-GFP antibodies, and this coimmunoprecipitation was prevented by incubation with excess recombinant GFP ( Figure 3A) . Therefore, the interaction of Tomosyn with Syntaxin is conserved in C. elegans.
We next addressed whether depletion of Tomosyn altered the distribution or abundance of t-SNAREs. When endogenously expressed UNC-64 Syntaxin and RIC-4 SNAP-25 were visualized by immunostaining, we observed similar distributions in wild-type and tomo-1 mutants ( Figures 3C and 3D ). Furthermore, axon morphology was superficially normal in immunostained tomo-1 mutants, suggesting that loss of Tomosyn does not grossly alter neurite outgrowth in C. elegans as has been suggested for cultured mammalian neurons (Sakisaka et al., 2004) . These results suggest that the increased secretion observed in tomo-1 mutants is unlikely to be explained by perturbations of t-SNARE distribution or axon morphology.
Mutants Lacking Tomosyn Have Increased SV Priming and Increased Synaptic Abundance of UNC-13
The pool of primed SVs can be measured by evoking fusion with hypertonic sucrose (Rosenmund and Stevens, 1996) . We found that the EPSC evoked by hypertonic sucrose was significantly increased in tomo-1 mutants compared to wild-type controls ( Figure 4B ). The total synaptic charge transfers evoked by a depolarizing stimulus and by sucrose were both increased by w400% in tomo-1 mutants (Figure 1B and Figures 4A and 4B) . These results suggest that the increased ACh secretion observed in tomo-1 mutants was caused by an increase in the pool of primed SVs, consistent with the idea that Tomosyn normally inhibits SV priming and secretion.
Since tomo-1 mutants have increased priming, we wondered whether the intracellular distribution of UNC-13 might be altered in these mutants. Two isoforms of UNC-13 (UNC-13S and UNC-13L) are expressed in C. elegans (Kohn et al., 2000) . UNC-13S is diffusely distributed in axons, but can become concentrated at sites of release under genetic or pharmacological conditions that correlate with increased neurotransmitter release (Nurrish et al., 1999) . Similar results have also been observed for Drosophila dUNC-13 (Aravamudan and Broadie, 2003) . To determine if Tomosyn regulates the synaptic abundance of UNC-13S, we monitored the distribution of GFP-tagged UNC-13S (UNC-13S::GFP) under its endogenous promoter (Nurrish et al., 1999). We observed a significant increase in the fluorescence intensity of UNC-13S::GFP puncta and a corresponding decrease in the intensity of the diffuse UNC-13S::GFP fluorescence in the dorsal nerve cord of tomo-1 mutants ( Figures 4C-4E ). The increased UNC-13S::GFP puncta intensity was accompanied by an increased puncta density, presumably because these puncta were more readily detected above the diffuse axonal fluorescence ( Figure 4E ).
To test if these UNC-13S::GFP puncta were localized to presynaptic elements, we coexpressed UNC-13S::GFP and monomeric RFP-tagged Synaptobrevin (RFP::SNB-1), expressed in cholinergic motor neurons. In tomo-1 mutants, the UNC-13::GFP and RFP::SNB-1 puncta were highly colocalized, although a subset of RFP::SNB-1 puncta did not have a corresponding UNC-13S::GFP accumulation ( Figure 4F ). Thus, loss of Tomosyn results in increased accumulation of UNC-13S at release sites.
Expression of Open-Syntaxin Reconstitutes SV Priming in unc-13 mutants The current opener model for SV priming proposes that open-Syntaxin promotes formation of partially assembled trans-SNARE complexes. This model predicts that expression of a constitutively open mutant form of Syntaxin (Dulubova et al., 1999) should increase the pool of primed SVs. Consistent with this idea, we found that the primed pool of vesicles (assayed as sucroseevoked EPSCs) was increased in oxIs34 [open-Syntaxin] transgenic animals compared to wild-type controls ( Figures 5A and 5B ). The opener model further proposes that UNC-13 promotes priming by stabilizing openSyntaxin, implying that the priming defect observed in unc-13 mutants is caused by a lack of open-Syntaxin. Consistent with this idea, sucrose-evoked EPSCs were significantly increased in unc-13; oxIs34 [openSyntaxin] double mutants (70% wild-type, p < 0.01) compared with unc-13 single mutants (8% wild-type, p < 0.01) ( Figure 5B ). These results confirm two important aspects of the opener model.
Does Tomosyn Act as a Buffer for Open-Syntaxin?
The ability of open-Syntaxin to promote SV priming suggests a potential model for Tomosyn function. Tomosyn binds to the t-SNAREs Syntaxin and SNAP-25 ( Figure 3A) , forming an inhibitory SNARE complex (Fujita et al., 1998; Hatsuzawa et al., 2003) . Therefore, Tomosyn might inhibit priming by limiting the access of Loss of Tomosyn Improves the Locomotion of unc-13 Mutants Mutants lacking UNC-13 have severe locomotion defects and are nearly completely paralyzed. We found that a tomo-1 mutation and expression of open-Syntaxin both partially restored movement to unc-13 mutants ( Figure 6 ). We documented this improved locomotion in two ways. First, we recorded movies of mutant animals (for movies, see the Supplemental Data). Time-lapse frames drawn from these movies illustrate the improved locomotion observed in tomo-1 unc-13 double mutants (Figures 6A-6D ). Second, we quantified locomotion rate (as body bends/30 s) ( Figure 6E ). While this restoration of movement to unc-13 mutants was easily observable, locomotion of the tomo-1 unc-13 and unc-13; oxIs34 [open-Syntaxin] double mutants was not restored to wild-type levels ( Figure 6E ). These results are in agreement with a prior study of open-Syntaxin effects on locomotion behavior .
The limited ability of open-Syntaxin to rescue the locomotion defect of unc-13 mutants may be due to the inhibitory effects of Tomosyn. To test this possibility we examined the locomotion behavior of tomo-1 unc-13; oxIs34 [open-Syntaxin] triple mutants. In these animals, locomotion was significantly improved (p < 0.01, Student's t test) compared to both double mutants ( Figures  6D and 6E) . Thus, loss of Tomosyn enhances the ability of open-Syntaxin to rescue the locomotion defects of unc-13 mutants.
Assaying the Effects of tomo-1 and Open-Syntaxin on Secretion with GFP-Tagged Synaptobrevin Changes in the distribution of SNB-1 can be used to infer changes in the functional status of nerve terminals. The fluorescence intensity of SNB-1 puncta correlates with the number of SVs at synapses. For example, GFP::SNB-1 puncta fluorescence increased 60% in unc-13 mutants (Figure 7) , which parallels the 74% increase in synaptic vesicle number observed in ultrastructural studies (Richmond et al., 1999) . The intensity of the diffuse SNB-1 fluorescence in axons (i.e., between puncta) correlates with the abundance of Synaptobrevin in the plasma membrane (Dittman and Kaplan, 2006) , which is a steady-state measure of the ratio of the rates of SV exocytosis and endocytosis (Fernandez-Alfonso and Ryan, 2004) . The intensity of the SNB-1 axon fluorescence was decreased by 40% in unc-13 mutants, consistent with the dramatic decrease in the rate of SV fusions observed by electrophysiology (Figure 7 ) (Richmond et al., 1999) . Thus, the distribution of GFP::SNB-1 can be used to assess changes in the SV cycle.
In tomo-1 mutants, we observed a 43% increase in GFP::SNB-1 axon fluorescence (p < 0.001, Student's t test) while puncta fluorescence was not significantly changed compared to wild-type controls (Figure 7) . These results suggest that the abundance of Synaptobrevin in the plasma membrane was increased in tomo-1 mutants. Thus, tomo-1 mutants have increased GFP::SNB-1 axon fluorescence ( Figure 7B ), increased The synaptic charge transfer for sucrose responses was measured for 1 s after initiation of the stimulus for wild-type and tomo-1(nu468). In (B), the numbers over the bars indicate the fold change relative to wild-type. Values that differ significantly from wild-type (**p < 0.01, Mann-Whitney) are indicated. (C) The distribution of UNC-13S::GFP, encoded by the nuIs46 transgene (Nurrish et al., 1999) , in the dorsal nerve cords of unc-13 single and tomo-1 unc-13 double mutants was compared. Scale bar, 10mm. UNC-13S::GFP puncta intensity (D) and density (E) were significantly increased (**p < 0.001, Student's t test) in tomo-1(nu468) unc-13(s69); nuIs46 (n = 31) animals compared to the unc-13(s69); nuIs46 (n = 29) controls. (F) UNC-13S::GFP (Green) and RFP::SNB-1 (Red) were expressed in DA motor neurons (using the unc-129 promoter) in tomo-1(nu468) unc-13(s69) double mutants and imaged along the dorsal nerve cord. Images were merged to illustrate colocalization. Error bars = SEM. Scale bar, 5 mm.
stimulus-evoked EPSCs ( Figure 1A) , and increased aldicarb sensitivity , all of which indicate an increased amount of SV fusions.
Next we examined whether tomo-1 mutations alone or in combination with open-Syntaxin expression could reverse the defect in GFP::SNB-1 distribution in unc-13 mutants. Axon fluorescence was significantly increased in both double mutants (p < 0.01) and in tomo-1 unc-13; oxIs34 [open-Syntaxin] (p < 0.01) triple mutants compared with unc-13 single mutants ( Figures 7A and 7B) . expression and loss of Tomosyn were both sufficient to restore a significant pool of primed vesicles in unc-13 mutants, and this effect was enhanced in the tomo-1 unc-13; oxIs34 [open-Syntaxin] triple mutant. Thus, loss of Tomosyn and expression of open-Syntaxin produced similar effects on locomotion, GFP::SNB-1, and the pool of primed vesicles in unc-13 mutants, and these effects were additive in triple mutants.
Eliminating Tomosyn Does Not Restore Nerve-Evoked Secretion to unc-13 Mutants Although both open-Syntaxin and tomo-1 mutations restored substantial levels of SV priming, they produced only modest improvement in the locomotion behavior of unc-13 mutants ( Figure 6E ). Thus, the overall level of synaptic transmission achieved in these double and triple mutants must be insufficient to produce normal behavior. To directly assess synaptic transmission, we recorded both stimulus-evoked and endogenous EPSCs. We found that the amplitude of stimulus-evoked EPSCs remained significantly reduced compared to wild-type controls in all mutant combinations lacking UNC-13 ( Figures 9A-9C ). For example, in tomo-1 unc-13; oxIs34 [open-Syntaxin] triple mutants, the sucroseevoked charge was 160% of wild-type levels, while the stimulus-evoked charge was 27% of wild-type, which was significantly greater than that observed in unc-13 single mutants (3% wild-type, p < 0.01). Similarly, the rate of endogenous EPSCs was significantly increased in both double mutants compared with unc-13 single mutants, and this effect was further enhanced in tomo-1 unc-13; oxIs34 [open-Syntaxin] triple mutants ( Figures  9D-9F) . However, the rates of endogenous EPSCs observed in double and triple mutants lacking UNC-13 were all significantly lower than those observed in wild-type controls ( Figures 9D-9F) . Thus, unc-13 defects in stimulus-evoked and endogenous EPSCs were not reversed by open-Syntaxin and tomo-1 lossof-function mutations, consistent with the modest improvement seen in locomotion. These results provide further evidence that, in addition to its role in SV priming, UNC-13 is also required for other aspects of secretion, as we previously proposed (Madison et al., 2005) . Our present results suggest that open-Syntaxin can reconstitute the priming function, but not the second UNC-13 function.
Discussion
The UNC-13 Munc13 family of proteins plays a critical role in the priming of SVs. Mutants lacking UNC-13 proteins are characterized by an almost complete elimination of SV priming and fusion (Aravamudan et al., 1999; Augustin et al., 1999; Richmond et al., 1999) , whereas overexpression of UNC-13 leads to increased synaptic transmission (Brose et al., 2000) . These results have been interpreted to mean that UNC-13 proteins play an essential role in the process of SV priming. Our results have several important implications for current models of priming.
The Role of Open-Syntaxin in SV Priming
Prior studies suggested that UNC-13 is absolutely required for priming (Aravamudan et al., 1999; Augustin et al., 1999; Richmond et al., 1999) , and that its function is mediated by stabilizing open-Syntaxin ). The principal result supporting this opener model was that expression of open-Syntaxin in unc-13 mutants was sufficient to restore normal levels of stimulus-evoked secretion ). By contrast, we find that the stimulus-evoked EPSC was only weakly improved in the unc-13; oxIs34 [open-Syntaxin] double mutant (peak amplitude 3% wild-type, evoked charge 10% wild-type). This discrepancy could result from differences in recording conditions or stimulus protocols.
In addition to stimulus-evoked responses, both our study and the work done by Richmond et al. (2001) provide several other measures of synaptic transmission. For all other assays, both studies agree, and both suggest that unc-13; oxIs34 [open-Syntaxin] double mutants have significantly reduced synaptic transmission. For example, in our study, remarkably consistent defects were observed for several parameters in unc-13; oxIs34 [open-Syntaxin] double mutants: total stimulusevoked charge 10% wild-type, rate of endogenous EPSCs 12% wild-type, locomotion rate 10% wild-type, and partial restoration of Synaptobrevin axonal fluorescence. Thus, the reduced stimulus-evoked EPSCs reported here are consistent with the majority of the data in both studies. These data would be difficult to reconcile with the fully rescued EPSC reported in the prior study.
Beyond these results, we provide three experiments to test the functional importance of open-Syntaxin in SV priming. We expressed open-Syntaxin in unc-13 single mutants and in tomo-1 unc-13 double mutants and measured the pool of primed SVs, as assayed by sucrose-evoked EPSCs. In both cases, we observed a significantly increased pool of primed SVs (70% and 160% wild-type, respectively) compared with that observed in unc-13 single mutants (8% wild-type). In a third case, open-Syntaxin single mutants, we observed a trend toward increased priming (160% wild-type), although this effect was not significant (p = 0.23). Thus, open-Syntaxin expression promotes SV priming and substantially bypassed the requirement for UNC-13 in priming. Two equally plausible models could account for these results. UNC-13 could promote priming by increasing the availability of open-Syntaxin, i.e., the original opener 
Tomosyn as an Inhibitor of SV Priming
Our results, together with previous experiments on cultured chromaffin cells, support the idea that Tomosyn inhibits priming of both secretory granules and SVs. Overexpression of Tomosyn in chromaffin cells reduced the number of fusion-competent vesicles, consistent with Tomosyn inhibition of secretory granule priming (Hatsuzawa et al., 2003; Yizhar et al., 2004) . Our results strengthen the connection of Tomosyn to priming by showing that mutants lacking Tomosyn have a significantly increased pool of primed vesicles and enhanced stimulus-evoked secretion. Thus, by both overexpression and loss-of-function studies, Tomosyn appears to inhibit priming and secretion. Interestingly, we found that tomo-1 mutants had an increased abundance of UNC-13S at synapses, which could contribute to the enhanced SV priming observed in tomo-1 mutants. On the other hand, depleting Tomosyn increased SV priming, even in mutants lacking UNC-13. Thus, Tomosyn inhibits priming in a manner that does not require UNC-13.
The abundance of GFP-tagged TOMO-1 at synapses was correlated with SV number. TOMO-1::GFP synaptic abundance was increased in exocytosis mutants (e.g., unc-13 and unc-18), which have increased numbers of SVs. Conversely, TOMO-1::GFP axonal abundance was decreased in mutants lacking the anterograde motor protein UNC-104 KIF1A, which have greatly decreased numbers of SVs (Hall and Hedgecock, 1991) . One potential explanation of these results is that Tomosyn associates with SVs and is cotransported with SV precursors. This possibility is further suggested by prior studies in which Tomosyn was found in synaptic vesicle fractions isolated from rat brain (Fujita et al., 1998) . Alternatively, it remains possible that Tomosyn and synaptic vesicle precursors are independently transported to presynaptic terminals, but that their steady-state abundances at terminals are correlated. Further experiments will be required to distinguish between these possibilities. Regardless of how Tomosyn is recruited to synapses, our results demonstrate that Tomosyn likely acts at synapses to locally inhibit SV priming and fusion. Consequently, one important task of the SV priming mechanism must be to overcome inhibition by Tomosyn. It is possible that Tomosyn's inhibitory function at synapses is regulated by protein kinases. For example, recent studies have suggested that the kinase PKA inhibits the association of Tomosyn with Syntaxin, which would likely increase SV priming (Baba et al., 2005) . Conversely, the Rho-associated kinase ROCK phosphorylates Syntaxin to increase the binding of Tomosyn, potentially negatively regulating priming (Sakisaka et al., 2004) . Interestingly, the ROCK phosphorylation site is located within a region of Syntaxin shown to be involved in UNC-13 binding (Betz et al., 1997) . These, or other, protein kinases could provide a mechanism for regulating Tomosyn's inhibitory activity.
Based on our results, we propose that Tomosyn inhibits priming by restricting the ability of open-Syntaxin to promote priming, i.e., by acting as a buffer for openSyntaxin. Several results support this model. First, Tomosyn and Syntaxin interact via their SNARE motifs; therefore, Tomosyn will form SNARE complexes only with open-Syntaxin. Second, this model predicts that loss of Tomosyn should increase the availability of endogenously expressed open-Syntaxin and consequently should produce effects that are very similar to those caused by transgenic expression of open-Syntaxin. Several results confirm this prediction. Open-Syntaxin and a tomo-1 mutation produced similar changes in several assays, including stimulus-and sucroseevoked EPSCs in single mutants and in double mutants lacking UNC-13. In addition, the ability of open-Syntaxin to restore priming and secretion in unc-13 mutants (assayed by behavior, imaging, and electrophysiology) was enhanced in tomo-1 mutants. These results suggest that Tomosyn acts as a buffer that restricts the ability of endogenously expressed open-Syntaxin to promote SV priming. Thus, the inhibitory effect of Tomosyn on SV priming suggests that endogenous open-Syntaxin and transgene-encoded open-Syntaxin are both able to stimulate SV priming and to bypass the requirement for UNC-13 in SV priming. These results all strongly support the idea that the availability of open-Syntaxin is a critical determinant of the SV priming mechanism.
Our results also suggest new insights into the mechanism of SV priming. Prior studies suggested that UNC-13 is absolutely required for SV priming, whereas we find that UNC-13 is more likely to play a regulatory role in this process. We propose that the near elimination of SV priming in unc-13 mutants is a consequence of the potent inhibition of priming by Tomosyn. We further propose that a critical aspect of the SV priming mechanism must be overcoming the inhibitory effects of Tomosyn at synapses. The current model for priming suggests that UNC-13 is required to form open-Syntaxin. Contrary to this opener model, our results suggest that significant levels of open-Syntaxin likely occur in mutants lacking UNC-13. In particular, we found that Tomosyn inhibits SV priming and secretion even in unc-13 mutants. These results imply that UNC-13 is not absolutely required for producing open-Syntaxin. It is possible that additional factors play important roles in regulating the abundance of open-Syntaxin. Alternatively, in the absence of Tomosyn, the open-to-closed conformational equilibrium may provide sufficient levels of open-Syntaxin to support SV priming. A similar model for ''spontaneous'' SV priming was recently proposed to account for the residual transmission at NMJs in mouse triple knockout mutants lacking Munc13-1, -2, and -3 (Varoqueaux et al., 2005) .
The Role of UNC-13 in SV Priming and StimulusEvoked Secretion
We recently reported that in addition to its role in priming, UNC-13 also acts after priming to promote stimulus-evoked SV fusion (Madison et al., 2005) . Our present results provide further support for this idea. In particular, we find that even when normal levels of SV priming are restored to unc-13 mutants (e.g., in tomo-1 unc-13; oxIs34 [open-Syntaxin] triple mutants), stimulus-evoked and endogenous EPSCs were not restored to normal levels. The persistent defects in nerve-evoked secretion in mutants lacking UNC-13 is consistent with the limited improvement in locomotion behavior seen in these mutants. Thus, open-Syntaxin can functionally bypass the priming function of UNC-13, but not the second (likely post-priming) function of UNC-13. While we favor the idea that the stimulus-evoked EPSC defect observed here is caused by a post-priming function for UNC-13, we cannot exclude the possibility that this defect could be caused by a structural alteration of active zones (e.g., failure to incorporate calcium channels).
The phenotype of tomo-1 single mutants also supports the duality of UNC-13 functions. Mutants lacking Tomosyn had a significantly enlarged pool of primed SVs and increased stimulus-evoked secretion. Absence of Tomosyn is predicted to increase the availability of open-Syntaxin, which would tend to increase SV priming, but not stimulus-evoked secretion. By contrast, increased recruitment of UNC-13 to synapses is predicted to promote increased SV priming and increased stimulus-evoked secretion, as was observed in tomo-1 mutants. Consequently, we propose that recruitment of UNC-13 serves two purposes-promoting SV priming and fusion. Both UNC-13 functions reside in the carboxy-terminal 700 amino acids of the protein (Basu et al., 2005; Madison et al., 2005; Stevens et al., 2005) . The priming function of UNC-13 can be bypassed by expressing open-Syntaxin, whereas the post-priming function depends upon the UNC-13-Syntaxin interaction and cannot be bypassed by open-Syntaxin. Thus, it seems likely that UNC-13 has functionally important targets other than Syntaxin.
An appealing model is that UNC-13 and Tomosyn serve as parallel mechanisms to regulate the availability of t-SNAREs. In this view, it would be the balance of inhibition by Tomosyn and activation by UNC-13 that controls priming and fusion of SVs. This antagonism between Tomosyn and UNC-13 could serve as an integration point for upstream pathways. G protein and second messenger pathways have been shown to alter the localization and abundance of UNC-13 (Aravamudan and Broadie, 2003; Nurrish et al., 1999) , and Ca 2+ /Calmodulin binding activates UNC-13 Munc13 (Junge et al., 2004) . In this manner, multiple signaling pathways converge on the priming mechanism, providing a mechanism to dynamically regulate the pool of fusion-competent vesicles at a synapse.
Experimental Procedures Strains
Strains were maintained at 20 C as described by Brenner (Brenner, 1974) . The following strains were used in this study: N2 Bristol, nuIs46 [Punc-13::UNC-13::GFP]; unc-13(s69) (KP2410), nuIs46; tomo-1(nu468) unc-13(s69) (KP4291), nuIs217 [Punc-17::TOMO-1::GFP]; tomo-1(nu468) (KP4277), nuIs217; unc-13(s69) tomo-1(nu468) (KP4281), nuIs217; ric-4(md1088) (KP4279), nuIs217; unc18(md299) (KP4278), nuIs217; unc-104(e1265) (KP4280), nuIs218 [Punc-129::TOMO-1::GFP] (KP4284), nuIs218; unc-13(s69) (BC168) , tomo-1(nu468) (KP3689), unc-13(s69); oxIs34 (KP3812), tomo-1(nu468) unc-13(s69); oxIs34 (KP3811), oxIs34; nuIs152 [Punc-129::GFP::SNB-1] (KP3819), unc-13(s69); nuIs152 (KP3815), tomo-1(nu468); nuIs152 (KP3816), unc-13(s69); oxIs34; nuIs152 (KP3818), tomo-1(nu468) unc-13(s69); oxIs34; nuIs152 (KP3820), unc-104(e1265) (CB1265), ric-4(md1088) (RM956), unc-18(md299) (RM299). Genotypes were confirmed by sequencing the indicated alleles.
Constructs and Transgenes cDNA encoding the splice form TOMO-1a was inserted into the Nhe-I site of the Fire Lab vector pPD::49.26. TOMO-1::GFP was constructed by adding a Not-I endonuclease site at nucleotide position 3351 after amino acid 1117 of TOMO-1a. A Not-I-flanked GFP fragment was subcloned in to create TOMO-1::GFP. This construct was digested with Sph-I and BamHI, and either the unc-17 or the unc-129 promoter was ligated upstream of TOMO-1::GFP to create plasmids KP#1421 and KP#1422, respectively. TOMO-1DHelix::GFP was created by adding a Not-I site and a stop codon (TAG) after amino acid 1043 of TOMO-1a, and then Not-I-flanked GFP was subcloned into the construct to create plasmid KP#1435. TOMO-1::GFP plasmids (25 ng/ml) were injected into worms along with KP#708 [Pttx-3::dsRed] (50 ng/ml) as a marker. Integrated lines nuIs217 [Punc-17::tomo-1::gfp] and nuIs218 [Punc-129::tomo-1::gfp] were subsequently isolated following ultraviolet irradiation. KP#1423 contains the unc-129 promoter cloned upstream of the UNC-13S genomic construct.
Colocalization experiments were preformed by injecting KP#1283, which is unc-129-promoted SNB-1 tagged with RFP. For TOMO-1::GFP studies, KP#1283 (25 mg/ml) was injected into nuIs218 along with the coinjection marker KP#1106 [Pmyo-2::nls-gfp] (4 ng/ml) and then crossed into applicable mutants. For UNC-13S::GFP colocalization, KP#1423 (75 ng/ul) was coinjected with KP#1283 (25 mg/ml) and KP#1106 (4 ng/ml) and crossed into unc-13(s69) animals.
Characterization of Additional Splice Forms of tomo-1 During cloning of tomo-1, we discovered two additional splice forms of tomo-1 that were not described in Wormbase or represented in EST libraries. We sequenced full length clones corresponding to these splice forms after performing RT-PCR using a primer complementary to the trans-splice acceptor (SL1). We have named these splice forms splice form D and splice form E. Splice form D results in a four amino acid insertion in the variable regions of Tomosyn, and splice form E results in a nine amino acid insertion in at the same site. Interestingly, this generation of multiple splice forms by exon skipping parallels what has been seen in this region of the Tomosyn gene in mice, leading this part of Tomosyn to be referred to as the hypervariable module (Groffen et al., 2005) . The mRNA sequences for these additional splice forms have been deposited in Genbank with the following accession number: AY997305 (M01A10.2D) and AY997306 (M01A10.2E).
Immunolabeling, Subcellular Fractionation, and Coimmunoprecipitations
For immunolabeling experiments, wild-type and tomo-1(nu468) worms were fixed using Bouin's fixative (Nonet et al., 1997) and labeled with either antibodies to UNC-64 Syntaxin (1:500), RIC-4 SNAP-25 (1:500), or UNC-10 RIM1 (1:50,000) (Koushika et al., 2001; Saifee et al., 1998; Weimer et al., 2003) . Cy5 conjugated secondary and tertiary antibodies were then applied at a concentration of 1:500, and animals were mounted and imaged.
For immunoprecipitation experiments, subcellular fractionation was performed on a mixed population of worms and membrane extracts were isolated as previously described (Dreier et al., 2005) . To detect coimmunoprecipitation of Syntaxin with TOMO-1, extracts were made using the nuIs217 strain and immunoprecipitations were performed on membrane extracts using a polyclonal anti-GFP antibody (abcam ab6673). Immunoprecipitations were performed as previously described in buffer containing 50 mM HEPES (pH 7.7), 150 mM KCl, 1% Triton X100, 10% Glycerol, and 1 mM MgOAc, with protease inhibitors (10 mg/mL leupeptin, 5 mg/mL chymostatin, 3 mg/mL elastinal, 1 mg/mL pepstatin A, and 1 mM PMSF) and 7 mM 2-Mercaptoethanol. Western blots were performed on immunoprecipitations with either an UNC-64 Syntaxin polyclonal antibody or a GFP monoclonal antibody (Clonetech JL-8).
Locomotion Imaging and Behavioral Assay
Movies were acquired in iMovies (Macintosh) on a Digital Handycam (Sony) camera attached to a Stemi SV11 stereomicroscope (Zeiss). Prior to movie capture animals were first transferred to agar plates containing no food for one hour at 20 C. Still frames were exported from iMovies and processed using Photoshop (Adobe). Images were thresholded to separate worms from the background, inverted, and smoothed using the noise filter with a 2 pixel radius. For each panel, two processed images that were separated by 90 s were then superimposed, with the first in the red and the second in the green channels.
To quantitate locomotion, body bend analysis was performed on 40 worms per genotype. Fifteen to twenty worms were transferred to an NGM plate without bacteria. 30 min later, locomotion rates were quantified as body bends/30 s. Ten animals were scored from each plate and four plates were scored for each genotype. A body bend was counted when the body posterior to the pharyngeal bulb was displaced either right or left relative to the midline of the animal. For N2, tomo-1 and oxIs34 body bends were scored for a duration of 30 s. tomo-1 unc-13, unc-13; oxIs34 and tomo-1 unc-13; oxIs34 animals were scored for 60 s.
Fluorescence Imaging
All fluorescent imaging experiments were done using a Zeiss Axiovert 100 microscope and Olympus Planapo 1003 (NA = 1.4) objective equipped with FITC/GFP or RFP filters and an ORCA CCD camera (Hamamatsu). Animals were immobilized with either 30 mg/ml BDM (Sigma) or 50 mM Sodium azide. Image stacks were captured and maximum intensity projections were obtained using Metamorph 4.5 software (Universal Imaging). Identical camera gain, exposure settings, and fluorescence filters were used for all the quantitative studies. Using these conditions, GFP fluorescence filled the 12 bit dynamic range, with minimal saturation.
Line scans of nerve cord fluorescence were analyzed in Igor Pro (WaveMetrics) using custom-written software (Burbea et al., 2002; Sieburth et al., 2005) . To calibrate our measurements of GFP fluorescence against the fluorescent output of the bulb, punctal fluorescence was expressed as a ratio of the absolute punctal fluorescence to the absolute mean fluorescence of 0.5 mm FluoSphere beads (Molecular Probes) measured during the experiment. Interpunctal fluorescence was similarly normalized. All fluorescence values are normalized to wild-type controls to facilitate comparison. Statistical significance was calculated using a Student's t test as previously described.
Electrophysiology
Strains for electrophysiology were maintained at 20 C on plates seeded with HB101. Adult worms were immobilized on Sylgard coated coverslips with cyanoacrylate glue. Animals were dissected in extracellular solution by making a dorsolateral incision and removing the gonad and intestines to reveal the underlying ventral nerve cord and body wall muscle quadrants as previously described. Animals were superfused in an extracellular solution containing (in mM) 127 NaCl, 5 KCl, 26 NaHCO 3 , 1.25 NaH 2 PO 4 , 20 glucose, 1 CaCl 2 , and 4 MgCl 2 bubbled with 5% CO 2 /95% O 2 at 18 C. Whole-cell recordings were carried out at 260 mV using an internal solution containing (in mM) 105 CH 3 O 3 SCs, 10 CsCl, 15 CsF, 4 MgCl 2 , 5 EGTA, 0.25 CaCl 2 , 10 HEPES, and 4 Na 2 ATP, adjusted to pH 7.2 using CsOH. Under these conditions we only observe endogenous acetylcholine EPSCs at 260 mV. Borosilicate pipettes with a tip resistance of 2 MU were used for recordings, and currents were amplified using an Axopatch 200B (Axon Instruments) patchclamp amplifier. An Olympus BX50 microscope with a 603 0.9 NA water immersion objective was used to visualize the preparation. Stimulus-evoked EPSCs were stimulated by placing a borosilicate pipette (5-10 mm) near the ventral nerve cord and applying a 0.4 ms, 30 mA square pulse using a stimulus current generator (WPI). Sucrose-evoked EPSCs were stimulated by pressure ejecting extracellular solution supplemented with 500 mM sucrose for 0.5 s proximal to the ventral cord. Sucrose-evoked responses were quantitated by computing total charge transfer for 1 s following the initiation of a hyperosmotic stimulus. To compensate for basal activity, a 1 s static baseline collected prior to the hyperosmotic stimulus was subtracted from the computed total charge transfer. Data was digitized and acquired at 10 kHz using a National Instruments A/D board with custom-made software written in Igor Pro (Wavemetrics). Endogenous EPSC event detection and analysis of evoked events was carried out in Igor Pro using custom written software. The stimulus artifact was removed for clarity. Decay kinetics for stimulusevoked EPSCs were analyzed by fitting a double exponential to the decay phase of each EPSC. The results were reported as a weighted average of the decay constants. Statistical significance was determined as previously described on a worm-by-worm basis using the Mann-Whitney, Student's t test, or the Kolmogorov-Smirnov test as indicated.
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